Clinicians should screen adults with type 2 diabetes or prediabetes for nonalcoholic fatty liver disease (NAFLD), according to a guideline update to the American Diabetes Association’s Standards of Care in Diabetes — 2023.
The recommendation is particularly relevant for patients with obesity or cardiometabolic risk factors and those with established cardiovascular disease, the update’s authors wrote. Early diagnosis will help to ensure the optimal outcomes, the ADA said.